Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1999
03/16/1999US5882627 Methods and compositions for in-vivo detection of oral cancers precancerous conditions
03/16/1999CA2236363A1 Novel compound
03/16/1999CA2186513C Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
03/16/1999CA2165012C Estrogen agonists
03/16/1999CA2164689C Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis
03/16/1999CA2160140C Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors
03/16/1999CA2158108C Compositions containing sertraline and a 5-ht1d receptor agonist or antagonist
03/16/1999CA2058264C Dihydrobenzofuran carboxamides and process for their preparation
03/11/1999WO1999011798A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999WO1999011788A1 Kringle1
03/11/1999WO1999011781A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/11/1999WO1999011753A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS
03/11/1999WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/11/1999WO1999011645A1 Poly(adp-ribose) polymerase ('parp') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999WO1999011637A1 Protease inhibitors
03/11/1999WO1999011629A1 Novel carboxylic acid derivatives, their production and their use as mixed eta/etb endothelin-receptor antagonists
03/11/1999WO1999011628A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/11/1999WO1999011626A1 Integrin receptor antagonists
03/11/1999WO1999011624A1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
03/11/1999WO1999011620A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
03/11/1999WO1999011608A1 Malonic acid based matrix metalloproteinase inhibitors
03/11/1999WO1999011606A2 Inhibitors of protein tyrosine phosphatase
03/11/1999WO1999011604A1 Sterilized 5-aminolevulinic acid
03/11/1999WO1999011283A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999WO1999011274A1 Use of purine nucleosides for modulating the axonal outgrowth of central nervous system neurons
03/11/1999WO1999011273A1 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
03/11/1999WO1999011266A1 Multiple sclerosis remedies
03/11/1999WO1999011264A1 Il-8 receptor antagonists
03/11/1999WO1999011263A1 Combination therapy comprising amlodipine and a statin compound
03/11/1999WO1999011259A1 Therapeutic combinations comprising amlodipin and atorvastatin
03/11/1999WO1999011258A1 Lymphocyte function antigen-1 antagonists
03/11/1999WO1999011257A1 Improved compositions and methods for the control of smoking
03/11/1999WO1999011253A1 Il-8 receptor antagonists
03/11/1999WO1999011251A1 Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
03/11/1999WO1998057984A3 Torsin, torsin genes, and methods of use
03/11/1999WO1998056771A3 Piperazine derivatives and their use as anti-inflammatory agents
03/11/1999WO1998055507A3 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
03/11/1999WO1998054212A3 Human type 3 ryanodine receptor protein and dna molecules coding therefor
03/11/1999WO1998052937A3 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
03/11/1999WO1998033509A3 Useful properties of human lactoferrin and variants thereof
03/11/1999DE19739685A1 Monoklonale Antikörper zur Therapie und Prophylaxe von Erkrankungen durch Clostridium difficile Monoclonal antibodies for the therapy and prophylaxis of diseases caused by Clostridium difficile
03/11/1999CA2304117A1 Integrin receptor antagonists
03/11/1999CA2303476A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/11/1999CA2302450A1 Il-8 receptor antagonists
03/11/1999CA2302364A1 Il-8 receptor antagonists
03/11/1999CA2302361A1 Protease inhibitors
03/11/1999CA2302350A1 Novel carboxylic acid derivatives, their production and their use as mixed eta/etb endothelin-receptor antagonists
03/11/1999CA2302248A1 Improved compositions and methods for the control of smoking
03/11/1999CA2302168A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
03/11/1999CA2302154A1 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
03/11/1999CA2302037A1 Malonic acid based matrix metalloproteinase inhibitors
03/11/1999CA2298601A1 Inhibitors of protein tyrosine phosphatase
03/11/1999CA2296758A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
03/11/1999CA2294133A1 Poly(adp-ribose) polymerase ("parp") inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
03/11/1999CA2294118A1 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
03/11/1999CA2294110A1 Alkoxy-substituted compounds, methods, and compositions for inhi biting parp activity
03/11/1999CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same
03/10/1999EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus
03/10/1999EP0900841A1 LAG-3 splice variants
03/10/1999EP0900799A1 Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/10/1999EP0900568A2 AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
03/10/1999EP0900567A2 Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
03/10/1999EP0900275A1 Methods and reagents for modulating apoptosis
03/10/1999EP0900272A2 Tumor necrosis factor alpha convertase
03/10/1999EP0900225A1 Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
03/10/1999EP0900221A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
03/10/1999EP0900219A1 Heterocyclic compounds
03/10/1999EP0900218A1 Heterocyclic compounds
03/10/1999EP0900217A1 Heterocyclic compounds
03/10/1999EP0900211A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
03/10/1999EP0900209A1 Thiazoline acid derivatives
03/10/1999EP0900204A1 Heterocyclic compounds
03/10/1999EP0900203A1 Quinoline derivatives, processes for their preparation, and their use as medicaments
03/10/1999EP0900202A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs
03/10/1999EP0900201A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
03/10/1999EP0900199A1 Azetidinone derivatives for the treatment of atherosclerosis
03/10/1999EP0900197A1 Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors
03/10/1999EP0900083A1 Novel substituted imidazole compounds
03/10/1999EP0900081A1 Inhibitors of farnesyl-protein transferase
03/10/1999EP0785769B1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof
03/10/1999EP0677039B1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
03/10/1999CN1210538A Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
03/10/1999CN1210531A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/10/1999CN1210529A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/10/1999CN1210528A Dihydrobenzofuran compounds useful as anti-inflammatory agents
03/10/1999CN1210527A Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/10/1999CN1210517A Hydroxamic acid derivatives for use with treatment of diseases related to connective tissue degradation
03/10/1999CN1210105A Process for preparation of 2,5-disubstituted pyridines
03/10/1999CN1209994A Use of inhibitors of sodium-hyfrogen exchanger for production of pharmaceutical for treatment of disorders which are caused by protozoa
03/10/1999CN1042429C 5-(1-fluoro-vinyl-1H-pyrimidine-2,4-dione derivatives, medicinal composition and preparation thereof
03/09/1999US5880284 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
03/09/1999US5880263 Human chemotactic protein
03/09/1999US5880152 Inflammatory bowel disease
03/09/1999US5880149 Metal complexes as cysteine protease inhibitors
03/09/1999US5880148 Treating diabetes, arterial hypertension, restenosis and atheromatous diseases
03/09/1999US5880141 Controlling, modulating and inhibiting tyrosine kinase signal transduction
03/09/1999US5880136 Sulfonamide fibrinogen receptor antagonists
03/09/1999US5880120 Treating depression by administering an antidepressant
03/09/1999US5880119 Angiotensin converting enzyme inhibitors; analgesics, hypotensive agents, diuretics; treating congestive heart failure, irritable bowel syndrome
03/09/1999US5880115 Steroid sulfatase inhibitors and methods for making and using the same
1 ... 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 ... 1564